跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 21,979 条关于
“Defence R&D Canada”
全部
21,979
临床试验
9,671
药物
2,862
机构
3,362
资讯
6,084
10个月前
Revive Therapeutics Advances Bucillamine Research for Nerve Agent Countermeasure in Collaboration with Canadian Defense Agency
去年
Revive Therapeutics Focuses R&D on Bucillamine for Infectious Diseases and Nerve Agent Exposure
6个月前
Revive Therapeutics Expands Bucillamine Patent Portfolio with North American Filings for Chemical Warfare Agent Treatment
2年前
Revive Therapeutics Advances Bucillamine Development for Long COVID Treatment Through Manufacturing Partnership
5个月前
HLB Life Science R&D Secures Two Major Government R&D Projects Worth $6.2 Million for AI Oncology and Medical Cannabis Development
去年
Viva Biotech Portfolio Companies Achieve R&D Milestones and Secure Funding
5年前
Patient-Centric Approach Could Transform Unsustainable Oncology R&D Landscape
去年
AstraZeneca Commits $570M Investment to Expand Canadian Operations and R&D Hub
9个月前
Federal R&D Budget Cuts Threaten US Biomedical Innovation Leadership
7个月前
Immunocore Restructures R&D Leadership as Executive VP Berman Departs
第 1 页,共 609 页
上一页
下一页